Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Liposomal Amphotericin B for IPA Prophylaxis
NCT00263315Phase 3Completed
- Sponsor
- Erasmus MC
- Start
- Jan 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amphotericin b in Invasive Pulmonary Aspergillosis (IPA), sponsored by Erasmus MC. Started Jan 2000; status: completed.
02
Drugs
amphotericin b
03
Conditions
Invasive Pulmonary Aspergillosis (IPA)
Beyond the preview
Go deeper on NCT00263315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00263315.